BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 7868895)

  • 1. Regulatory regions 3' of the immunoglobulin heavy chain intronic enhancer differentially affect expression of a heavy chain transgene in resting and activated B cells.
    Sigurdardottir D; Sohn J; Kass J; Selsing E
    J Immunol; 1995 Mar; 154(5):2217-25. PubMed ID: 7868895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deletion of a recombined Ig heavy chain transgene in B-lineage cells of transgenic mice.
    Heinzelmann A; Kumar S; Noggle S; Goedegebuur I; Sauer KM; Rath S; Durdik JM
    J Immunol; 1998 Jul; 161(2):666-73. PubMed ID: 9670941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of hypermutation in immunoglobulin heavy chain passenger transgenes.
    Johnston JM; Ihyer SR; Smith RS; Tai KF; Farmer T; Korsmeyer SJ; Nadon NL; Carroll WL
    Eur J Immunol; 1996 May; 26(5):1058-62. PubMed ID: 8647167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ig heavy chain protein controls B cell development by regulating germ-line transcription and retargeting V(D)J recombination.
    Schlissel MS; Morrow T
    J Immunol; 1994 Aug; 153(4):1645-57. PubMed ID: 8046237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Human immunoglobulin heavy-chain gene intronic enhancer segment HE2 (microB) functions as a major B-cell specific cis-element at cellular level as well as in transgenic mice].
    Enjoji M
    Fukuoka Igaku Zasshi; 1992 Jun; 83(6):262-74. PubMed ID: 1511952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Somatic hypermutation of a lambda 2 transgene under the control of the lambda enhancer or the heavy chain intron enhancer.
    Klotz EL; Storb U
    J Immunol; 1996 Nov; 157(10):4458-63. PubMed ID: 8906822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B cell deletion, anergy, and receptor editing in "knock in" mice targeted with a germline-encoded or somatically mutated anti-DNA heavy chain.
    Pewzner-Jung Y; Friedmann D; Sonoda E; Jung S; Rajewsky K; Eilat D
    J Immunol; 1998 Nov; 161(9):4634-45. PubMed ID: 9794392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-level expression of a human immunoglobulin gamma 1 transgene depends on switch region sequences.
    Gram H; Zenke G; Geisse S; Kleuser B; Bürki K
    Eur J Immunol; 1992 May; 22(5):1185-91. PubMed ID: 1577061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancer sequences located 3' of the mouse immunoglobulin lambda locus specify high-level expression of an immunoglobulin lambda gene in B cells of transgenic mice.
    Eccles S; Sarner N; Vidal M; Cox A; Grosveld F
    New Biol; 1990 Sep; 2(9):801-11. PubMed ID: 2126202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. B-cell tumorigenesis in mice carrying a yeast artificial chromosome-based immunoglobulin heavy/c-myc translocus is independent of the heavy chain intron enhancer (Emu).
    Palomo C; Zou X; Nicholson IC; Bützler C; Brüggemann M
    Cancer Res; 1999 Nov; 59(21):5625-8. PubMed ID: 10554044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of switch hybrid DNA between Ig heavy chain-mu and downstream switch regions in B lymphocytes.
    Müller JR; Giese T; Henry DL; Mushinski JF; Marcu KB
    J Immunol; 1998 Aug; 161(3):1354-62. PubMed ID: 9686598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A second B cell-specific enhancer 3' of the immunoglobulin heavy-chain locus.
    Pettersson S; Cook GP; Brüggemann M; Williams GT; Neuberger MS
    Nature; 1990 Mar; 344(6262):165-8. PubMed ID: 2106628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutting edge: IFN-gamma regulated germline transcripts are expressed from gamma2a transgenes independently of the heavy chain 3' enhancers.
    Collins JT; Dunnick WA
    J Immunol; 1999 Dec; 163(11):5758-62. PubMed ID: 10570257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipopolysaccharide-dependent transactivation of the temporally regulated immunoglobulin heavy chain 3' enhancer.
    Arulampalam V; Grant PA; Samuelsson A; Lendahl U; Pettersson S
    Eur J Immunol; 1994 Jul; 24(7):1671-7. PubMed ID: 7517878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A system for precise analysis of transcription-regulating elements of immunoglobulin genes.
    Cheng EY; Collins C; Berru M; Shulman MJ
    BMC Biotechnol; 2005 Oct; 5():27. PubMed ID: 16202157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complex mechanisms for inhibition of immunoglobulin gene expression in a germinal center B cell line.
    Bernstein RM; Mills FC; Mitchell M; Max EE
    Mol Immunol; 2004 May; 41(1):63-72. PubMed ID: 15140576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endogenous Ig production in mu transgenic mice. I. Allelic exclusion at the level of expression.
    Imanishi-Kari T; Bandyopadhay S; Busto P; Huang CA
    J Immunol; 1993 Apr; 150(8 Pt 1):3311-26. PubMed ID: 8468473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of IgM and IgD heavy chain gene expression: effect of abrogation of intergenic transcriptional termination.
    Yuan D; Witte PL; Tan J; Hawley J; Dang T
    J Immunol; 1996 Sep; 157(5):2073-81. PubMed ID: 8757329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ig heavy chain expression and class switching in vitro from an allele lacking the 3' enhancers DNase I-hypersensitive hs3A and hs1,2.
    Saleque S; Singh M; Birshtein BK
    J Immunol; 1999 Mar; 162(5):2791-803. PubMed ID: 10072526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Virtually identical enhancers containing a segment of homology to murine 3'IgH-E(hs1,2) lie downstream of human Ig C alpha 1 and C alpha 2 genes.
    Chen C; Birshtein BK
    J Immunol; 1997 Aug; 159(3):1310-8. PubMed ID: 9233627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.